AUTHORIZED USE

  • Emergency uses of the vaccine have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is authorized in individuals 6 months of age and older as a primary series. The Moderna COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 18 years of age and older.

  • The EUA for these products is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.

  • For more information on the EUA authorized uses of the vaccine, refer to the Fact Sheets for Healthcare Providers Administering Vaccine (Vaccine Providers) and Full Prescribing Information.

Moderna COVID-19 Vaccine, Bivalent is now authorized

The updated booster from Moderna is designed to help protect against multiple COVID-19 variants in a single shot.

See Frequently Asked Questions

Overview for Vaccine Recipients

Primary series 1 month between shots

Initial Adult Vaccination

Looking for information on adult primary series vaccination?

Visit spikevax
(COVID‑19 vaccine, mRNA)
mRNA in a fatty particle

What Is Moderna COVID‑19 Vaccine?

The Moderna COVID‑19 Vaccine uses mRNA to provide a blueprint for your cells to build your body's defense against SARS‑CoV‑2, the virus that causes COVID‑19.

Learn more about the vaccine

What Do We Know About the Safety of the Vaccine?

Overall, approximately 39,000 participants aged
6 months and older received at least 1 dose of Moderna COVID‑19 Vaccine in 5 clinical trials.

See what is known about vaccine safety

Frequently Asked
Questions

Do you have more questions about the Moderna COVID‑19 Vaccine? Take a look at our answers to the questions we hear most often.

View FAQ